Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity

Brain Research Bulletin

Volumn 55, Issue 5, 2001, Pages 579-584

  Reynolds, Gavin P ^a   Zhang, Zhi Jun ^a   Beasley, Clare L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Calbindin; Calretinin; GABA; Human brain; Parvalbumin; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; FLUNITRAZEPAM; GLUTAMATE DECARBOXYLASE; NEUROLEPTIC AGENT; PARVALBUMIN; SYNAPTOPHYSIN;

4 AMINOBUTYRIC ACID UPTAKE; BRAIN REGION; BRAIN TISSUE; FRONTAL CORTEX; GABAERGIC SYSTEM; HUMAN; INTERNEURON; NEUROPATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEURAL INHIBITION; SCHIZOPHRENIA;

EID: 0035878140     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00526-3     Document Type: Review

References (63)

1. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development
2. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
3. Postnatal development of parvalbumin immunoreactivity in axon terminals of basket and chandelier neurons in monkey neocortex
4. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics
5. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
6. Quantitative cytoarchitectural analyses of the cerebral cortex of schizophrenics
7. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
8. Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics
9. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects
10. Uncoupling of GABA-A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain
11. Parvalbumin in the monkey striate cortex; A quantitative immunoelectron microscopy study
12. Schizophrenia and the brain; A prospective clinico-neuropathological study
13. Calbindin D-28K and parvalbumin in the rat nervous system
14. No alterations in the density of parvalbumin or calretinin immunoreactive neurons in the anterior cingulate (BA 24b/c) in schizophrenia or bipolar disorder
15. Schizophrenia and anteroventral thalamic nucleus; selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons
16. Local circuit neurons of the prefrontal cortex in schizophrenia; Selective increase in the density of calbindin-immunoreactive neurons
17. Synapses of double bouquet cells in monkey cerebral cortex visualised by calbindin immunoreactivity
18. Visualisation of chandelier cell axons by parvalbumin-immunoreactivity in monkey cerebral cortex
19. Parvalbumin immunoreactivity reveals layer IV of monkey cerebral cortex as a mosaic of microzones of thalamic afferent terminations
20. Heterogeneity of GABAergic cells in cat visual cortex
21. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex
22. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia; Regional and diagnostic specificity
23. 3H-Muscimol binding sites are increased in autopsied brains of chronic schizophrenics
24. Changes in Ca2+-binding proteins in human neurodegenerative disorders
25. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities
26. Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics
27. Immunocytochemical localisation of calretinin in the forebrain of the rat
28. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients
29. Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics
30. Fast spiking cells in the rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin
31. GABAergic cell subtypes and their synaptic connections in rat frontal cortex
32. Benzodiazepine receptors; Increase in post-mortem brain of chronic schizophrenics
33. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex
34. Corticotropin-releasing factor immunoreactivity in monkey neocortex; An immunohistochemical analysis
35. Heterogeneity of chandelier neurons in monkey neocortex; Corticotropin-releasing factor and parvalbumin-immunoreactive populations
36. Local circuit neurons of developing and mature macaque prefrontal cortex; Golgi and immunocytochemical characteristics
37. Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex; Laminar, regional and target specificity of type I and type II synapses
38. Prenatal development of neurons in the human prefrontal cortex; II. A quantitative Golgi study
39. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia
40. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia; Focus on GABA content, GABA(A) receptors alpha-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression
41. Glutamate receptor dysfunction and schizophrenia
42. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors
43. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
44. Analysis of the ratio of calretinin-expressing interneurons and pyramidal neurons in the hippocampus of patients with schizophrenia
45. GABAergic neuronal subtypes in human frontal cortex-Development and deficits in schizophrenia
46. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
47. Hippocampal benzodiazepine receptors in schizophrenia
48. Selective deficits of frontal cortical GABAergic neuronal subtypes defined by calcium binding proteins in psychotic illness
49. Hypothesis suggesting that there is a defect in the GABA system in schizophrenia
50. Peptides, the limbic lobe and schizophrenia
51. Immunohistochemical markers in rat cortex; Colocalisation of calretinin and calbindin D28k with neuropeptides and GABA
52. Abnormally high neuronal density in the schizophrenic cortex
53. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients; Application of a three-dimensional, stereologic counting method
54. Reduced GABA uptake sites in the temporal lobe in schizophrenia
55. Different populations in the visual cortex and hippocampus of cat contain somatostatin or cholecystokinin-immunoreactive material
56. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia
57. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain
58. The Stanley Foundation brain collection and neuropathology consortium
59. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients
60. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia
61. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia
62. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons
63. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia